Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Samsung Bioepis and Biogen Secure EC Approval for OPUVIZ™, Aflibercept Biosimilar
Tuesday, November 19, 2024Samsung Bioepis in collaboration with Biogen has received European Commission EC approval for OPUVIZ SB a biosimilar referencing aflibercept OPUVIZ is indicated for adult patients to treat neovascular wet agerelated macular degeneration AMD macular o...
SK Biopharmaceuticals Enters into Agreement with KIRAMS for Actinium-225-Based Radiopharmaceutical Research
Tuesday, November 19, 2024SK Biopharmaceuticals has entered a collaborative agreement with the Korea Institute of Radiological and Medical Sciences KIRAMS to develop preclinical radiopharmaceutical drug candidates
VelaVigo and Avenzo Partner to Advance Nectin4/TROP2 Bispecific Antibody-Drug Conjugate
Tuesday, November 19, 2024VelaVigo Cayman has entered into an agreement with Avenzo Therapeutics The partnership grants Avenzo an exclusive option to license develop manufacture and commercialise a novel NectinTROP bispecific ADC globally excluding Greater China
AstraZeneca’s Tagrisso Recommended for EU Approval in Treating Advanced NSCLC
Monday, November 18, 2024AstraZenecas Tagrisso has been recommended for approval by the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP for use in adult patients with locally advanced unresectable nonsmall cell lung cancer NSCLC
Acepodia Secures FDA Approval for ACE1831 in IgG4-Related Disease
Saturday, November 16, 2024Acepodia has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for ACE IgGRelated Disease IgGRD is a rare autoimmune condition characterised by inflammation and fibrosis in multiple organ...
Janssen Receives CHMP Endorsement for Amivantamab-Lazertinib Combination in EGFR-Mutated Advanced NSCLC
Saturday, November 16, 2024Janssen has announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has recommended marketing authorisation for LAZCLUZE lazertinib in combination with RYBREVANT amivantamab
Numab Therapeutics and Kaken Pharmaceutical Collaborate on ND081 for Inflammatory Bowel Disease
Saturday, November 16, 2024Numab Therapeutics has partnered with Kaken Pharmaceutical to advance the development of ND Inflammatory Bowel Disease IBD is a chronic condition causing inflammation in the digestive tract primarily including Crohns disease and ulcerative colitis Sy...
Merck Gains Global Licence for LaNova’s Investigational Antibody LM-299
Friday, November 15, 2024Merck has entered a global licensing agreement with LaNova Medicines to advance LM a new investigational bispecific antibody targeting PD and VEGF LM is designed to simultaneously target immune checkpoint and angiogenesis pathways
PTC Therapeutics Gains FDA Approval for Gene Therapy Targeting AADC Deficiency
Friday, November 15, 2024PTC Therapeutics has received accelerated approval from the US Food and Drug Administration FDA for its gene therapy KEBILIDI eladocagene exuparvovectneq marking the first gene therapy in the United States administered directly into the brain
Celltrion Announces Acquisition of iQone Healthcare
Friday, November 15, 2024Celltrion has announced its acquisition of iQone HealthcareThe transaction expected to be finalized by Q marks a pivotal step in Celltrions strategy to expand its presence across Europe
